Networked Healthcare: Integration through sustainable value creation

Journal of Medical Marketing

Volumn 7, Issue 2, 2007, Pages 102-113

  Sobrio, Andrea ^a   Keller, Martina ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247500289     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1057/palgrave.jmm.5050073     Document Type: Article

References (15)

1. Case details and names known by the authors.
2. Pollack, A. (2006). Stanford to ban drug makers' gifts to doctors, even pens. New York Times, 12th September, 2006.
3. Fischer, A. (2006). Stanford University to ban gifts from drugmakers. Firstworld Medical Email Newsletter, 12th September, 2006.
4. Pesse, M., Erat, P. & Erat, A. (2006). The network is the customer. Setting the stage for fundamental change in pharmaceutical sales and marketing. J. Med. Market. 6(3), 165-171.
5. Mediatrack (2005). Media analysis for EFPIA of reaction to the pharmaceutical industry. Mediatrack Company publication, September 2005, p.7.
6. Corporate reputation survey conducted among 350 medical professionals and 88 individuals from other stakeholder groups, detailed reference withheld due to client confidentiality.
7. Meier, M. & Müller, I. (2006). Networked healthcare: A practical guide to understanding influence networks in the healthcare industry. J. Med. Market. 6(4), 250-259.
8. Erat, P. & Zorzi, O. (2007). Organising for networked healthcare - towards future organisational models. J. Med. Market. 7(1), 6-17.
9. Eckelmann, O. (2003). Business case for sustainability - Pharmaceutical industry report. IMD Working Paper Series, 2003-11, IMD, Lausanne.
10. Porter, M. & Olmsted Teisberg, E. (2006). Redefining Health Care. Creating Value-Based Competition on Results, Harvard Business School Press, Boston, MA, p. 4.
11. PMLive. GSK agrees 'risk-sharing' price schemes with European governments. Pharmaceutical Marketing Live, 19th September, 2006.
12. Neue Zürcher Zeitung. Preisbremse für Roche-Umsatzrenner, 10th October, 2006.
13. Referring to the'Dow Jones Sustainability Index' and the sustainability focused company assessment by the rating agency SAM-Group (www.sustainability-indexes.com and www.sam-group.com).
14. PMLive. Roche defends involvement in cancer campaign. Pharmaceutical Marketing Live, 24 October, 2006.
15. Eichacker, P.G., Natanson, C. and Danner, R. Surviving sepsis - practice guidelines, marketing campaigns, and Eli Lilly. New Engl. J. Med. 355, (16), 16 October 2006.